Who owns the WE NUKE CANCER trademark?

The WE NUKE CANCER trademark is owned by Actinium Pharmaceuticals, Inc..

What is the serial number for WE NUKE CANCER?

The USPTO serial number for WE NUKE CANCER is 99698638.

What is the registration number for WE NUKE CANCER?

WE NUKE CANCER is registered under USPTO registration number 0.

WEN

USPTO Trademark Record

PENDING

WE NUKE CANCER

Q: What class is the WE NUKE CANCER trademark registered in?

The WE NUKE CANCER trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 99698638·Reg 0·Filed Mar 12, 2026

Owner Actinium Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

WE NUKE CANCER (Serial No. 99698638), Registration No. 0, is a pending US trademark filed on Mar 12, 2026 by Actinium Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Statement of Use due: January 28, 2027120 days remaining

Mark Intelligence

WE NUKE CANCER (Reg. #0) is a pending US trademark that was filed in 2026 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 12, 2026

SERIAL

99698638

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

Actinium Pharmaceuticals, Inc.

Entity

Corporation

State

Address

100 Park Avenue, 23rd Floor, New York, NY, 10017

Country

Attorney

NameMichael E. Dukes

Law firm

Michael E. Dukes Dentons Cohen & Grigsby, P.C.

Docket

TM26-006

Address

625 Liberty Ave., Pittsburgh, PA 15222, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateMar 12, 2026

Serial Number99698638

Registration No.0

Registration DateDec 31, 1969

Status DateJul 28, 2026

Published for OppositionJun 02, 2026

Mark TypeStandard characters

Attorney DocketTM26-006

Status DescriptionLive and pending, notice of allowance issued

Filing Signals

FILED

2026

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

13 events

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 28, 2026

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jun 02, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 02, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 27, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

May 05, 2026

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

May 05, 2026

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

May 05, 2026

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

May 05, 2026

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 05, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Apr 29, 2026

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

Mar 12, 2026

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 12, 2026

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Mar 12, 2026

APPLICATION FILING RECEIPT MAILED

WE NUKE CANCER

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Actinium Pharmaceuticals, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Michael E. Dukes

Resources

Company